MarketWatch Automation
Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN -7.87% slid 7.37% to $8.92 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.89% falling 0.35% to 4,685.25 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.30% falling 0.31% to 36,319.98. This was the stock's second consecutive day of losses. Ocugen Inc. closed $9.85 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock underperformed when compared to some of its competitors Tuesday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM +0.65% rose 1.32% to $2.30, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL -2.65% rose 7.46% to $7.63, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD -4.37% fell 3.31% to $117.78. Trading volume (31.4 M) remained 4.8 million below its 50-day average volume of 36.2 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Add to watchlist
OCGN
Add to watchlist
DJIA
Add to watchlist
ADVM
Add to watchlist
OCUL
Add to watchlist
KOD
